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INTRODUCTION 
Interleukin-2 (IL-2) is a soluble immunomodulator that plays a 
central role in cell-mediated immunity by augmenting the proliferation 
and activity of T lymphocytes. Stimulation of these cells requires not 
only activation by an antigen, but activation by an antigen in 
association with the gene products of the major histocompatibility 
complex (MHC). Non-MHC loci also affect the immune response. The 
genetic control of the immune response, therefore, is mediated by gene 
loci encoded within and outside the MHC. 
There have been a paucity of reports describing the genetic control 
of IL-2 production. It has been demonstrated that MHC loci does not 
affect levels of IL-2 production (for a review, see Farrar et al., 1982). 
Non-MHC gene loci, however, have been shown to influence levels of 
production of and response to IL-2 in mice (Wofsy et al., 1981; Kawamura 
et a 1. , 1986) . 
A great deal of work has been aimed at determining the mechanism of 
action of IL-2 in the mammalian immune system. Studies of avian IL-2, 
however, have not received the same attention. The paucity of reports 
concerning avian IL-2 has been primarily due to the absence of an 
efficient and effective assay to measure avian IL-2 activity. Recently, 
Kromer et al. (1984) have made the study of avian IL-2 possible by 
developing an assay to measure avian IL-2 activity. 
The purpose of this study was to utilize the avian IL-2 assay to 
determine whether levels of IL-2 production are genetically controlled. 
The diversity of genetic stocks available at the Iowa State University 
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Poultry Research Center, which differ at their MHC and/or non-MHC 
regions, are a useful tool for determining whether any genetic influences 
that may be present can be attributed to MHC or non-MHC effects. 
Therefore, relative levels of IL-2 production of the various genotypes 
were measured to determine whether MHC and/or non-MHC influences mediate 
levels of IL-2 production. In addition, once levels of IL-2 production 
have been determined, relative abilities to produce IL-2 were compared 
with their known responses to different antigenic challenges to determine 
whether levels of IL-2 production correlate with the ability to mount an 
immune response to an antigenic challenge. 
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LITERATURE REVIEW 
The discovery that lymphocyte culture supernatants contained soluble 
mitogenic factors was made possible by the previous observation that 
plant lectins promoted the proliferation of T cells in vitro (Kasakura 
and Lowenstein, 1965; Gordon and Maclean, 1965). Since 1965, many 
mitogenic factors for lymphocytes have been reported including: 
thymocyte stimulating factor (TSF), thymocyte mitogenic factor (TMF), T 
cell growth factor (TCGF), co-stimulator, killer cell helper factor 
(KHF), and secondary cytoxic T cell inducing factor (SCIF) (Farrar et 
al., 1978; Gillis et al., 1978; Shaw et al., 1978; Wagner and 
Rollinghoff, 1978). The plethora of mitogenic factors that had similar 
functions and were being reported under different names created a great 
deal of confusion in the field. In 1979, researchers met at the Second 
International Lymphokine Workshop and determined that each of these 
mitogenic factors were identical and resolved to designate this soluble 
mitogenic factor interleukin-2 (IL-2) (Aarden et al., 1979). 
Cellular Functions of IL-2 
IL-2 is described as a soluble immunoenhancing factor produced 
primarily by helper T cells (Ttt) following activation with antigen or 
mitogen in the presence of interleukin-I (IL-1) (Farrar et al., 1982). 
Some of the immunoenhancing properties of IL-2 include: the promotion of 
mitogen- or antigen-stimulated T cell proliferation, the maintenance of 
cytotoxic T cell (CTL) lines, and the augmentation of T cell 
proliferation in mixed lymphocyte reactions (for review, see Farrar et 
al., 1982). The production of and response to IL-2 is antigen dependent 
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(Smith, 1984). However, levels of production of and receptor expression 
for IL-2 have been shown to have some degree of genetic regulation (Wofsy 
et al., 1981; Kawamura et al., 1986). 
Immunoenhancinq properties of IL-2 
Following the observation by Morgan et al. (1976) that conditioned 
media from lectin-stimulated mononuclear cells contained a soluble factor 
that would support the growth of lectin-activated T cells, researchers 
began to investigate the function of this soluble factor (IL-2) in T cell 
proliferation. IL-2 was determined to be necessary for the long-term 
growth and clonal expansion of CTLs since these cells do not grow in the 
absence of IL-2 while the addition of exogeneous IL-2 will promote their 
growth (Gillis and Smith, 1977a; Gillis and Smith, 1977b). Wagner and 
Rollinghoff (1978) later provided evidence that IL-2 producing cells were 
distinct from IL-2 responding cells. They observed that Ly 1+ (TH) cells 
were responsible for production, whereas antigen-primed Ly 23+ (CTL) 
cells responded to IL-2. 
Concurrently, investigators observed that another soluble factor, 
IL-1, which is released by macrophages, also appeared to play a role in 
the proliferation of T cells as well as the enhancement of IL-2 
production. To differentiate and determine the role of these soluble 
factors in T cell activation, an experiment using resting splenic T cells 
as well as blast T cells cultured with or without concanavalin A (Con A) 
in the presence or absence of IL-1 and/or IL-2 was performed (Larsson et 
al., 1980b). They found that the growth induction of resting T cells was 
greatly enhanced by the addition of both Con A and IL-1 compared to 
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either added alone. The addition of IL-2 alone or IL-2 and IL-1 to the 
resting T cell cultures did not induce their growth. However, the 
addition of IL-2 with Con A did promote T cell growth. Conversely, the 
addition of Con A and IL-1 did not enhance the proliferation of the blast 
cells. In addition, the presence of IL-2 in any combination or alone 
induced the growth of the T cell blast cultures. A similar experiment 
using phytohemagglutinin (PHA) showed that IL-2 production was dependent 
on the presence of both the lectin and IL-1 (Smith, 1980). Therefore, 
there appeared to be two signals required for IL-2 production: lectin or 
antigen attachment to the T cell and the simultaneous activation of these 
T cells by IL-1. 
The immunoenhancing properties of IL-2 have been defined by its role 
in the in vitro T cell culture systems. After it was determined that the 
soluble factor found in the culture supernatants played an intricate role 
in T cell proliferation, investigators began to use the supernatant as a 
tool to study the processes involved in T cell responses. 
Following the observation by Morgan et al. (1976) of a soluble 
factor that would promote T cell proliferation, Gillis and Smith (1977b) 
showed that this factor would support the long-term growth of CTLs while 
maintaining specificity for the antigen which initially activated them. 
Early studies using primary mixed lymphocyte cultures (MLC) suggested 
Ly 1+ (TH) cells amplify Ly 23+ (CTL) cells via a soluble factor (Altman 
and Cohen, 1975; Plate, 1976). 
Wagner and Rollinghoff (1978), using secondary MLCs, provided 
definitive evidence which established the role of IL-2 and identified the 
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cells which produced and responded to it. Their experiment was based on 
three previous observations: 1) secondary MLCs contained a soluble 
factor that enhanced the activation of CTLs (Uotila et al., 1978; Ryser 
et al., 1978), 2) the in vitro addition of Con A, a polyclonal activator 
of T cells, to in vivo-sensitized alloimmune T cells enhanced secondary 
CTL responses with specificity to the alloantigen used for the primary 
sensitization (Heininger et al., 1976; Bonavida, 1977), 3) CTLs specific 
for H-2K or H-20 (Class I) alloantigens were stimulated in a secondary 
MLC by cells sharing only the I region (Class II) alloantigens (Alter et 
al., 1976). With these observations in mind, Wagner and Rollinghoff 
(1978) conducted a study using supernatants from Con A activated T cells 
or I region incompatible MLCs and found that both were effective in 
inducing H-2K or H-20 specific CTL responses. Since it had already been 
demonstrated that Ly 1+ (TH) cells recognize the I region whereas Ly 23+ 
(CTL) cells recognize the K and 0 regions, they postulated that activated 
Ly 1+ T cells produced IL-2 and previously stimulated Ly 23+ cells 
responded to IL-2 (Cantor and Boyse, 1975; Nagy et al., 1976). 
Therefore, two T cell subclasses were necessary for an IL-2-dependent T 
cell response, the activated-TH cell which was responsible for production 
of IL-2, and the antigen-primed CTL which responded to IL-2. 
Once the role of the soluble factors, IL-1 and IL-2, and the cells 
involved in T cell proliferation had been defined, the events leading to 
a cell-mediated response could be determined. The role of IL-2 in the 
enhancement of CTL proliferation occurs as follows (Figure 1) (Farrar et 
al., 1982; Robb, 1984): 1) An accessory cell (e.g., macrophage) 
Figure 1. Cellular interactions influenced by IL-2 
Ag, antigen; AC, accessory cell; MHC, major 
histocompatibility complex; THP• precursor of helper T 
cells; THACj• activated helper T cell; TH. helper T cell; 
IL-1, inter eukin l; IL-2, interleukin 2; CTLp, cytotoxic 
T lymphocyte precursor; CTLACT• activated cytotoxic T 
lymphocyte; NK, natural killer cell; T5, suppressor T 
cell; IFN-~, gamma interferon; BCGF, B cell growth factor; 
BCDF, B cell differentiating factor; BACT• activated B 
cell. 
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attaches to an antigen or mitogen. 2) A precursor TH cell becomes 
activated to respond to IL-1 after prior recognition of the antigen or 
mitogen along with the class II determinant on the accessory cell. 3) 
IL-1 is released by the accessory cell and the activated TH cell 
undergoes blastogenesis and proliferates to a TH cell that secretes IL-2. 
4) Concurrently, a precursor CTL cell has combined with another 
accessory cell via recognition of the antigen or mitogen along with the 
class I determinant. This cell has now been activated to produce 
receptors for IL-2. 5) Upon stimulation by IL-2, the CTL undergoes 
blastogenesis and production of mature CTLs occur which have specificity 
for the antigen that activated it. 
Shortly after it was demonstrated that IL-2 augmented CTL responses, 
additional immumoenhancing properties of IL-2 on other cell types were 
reported. IL-2 was also shown to activate the other functional T cell 
subtypes which include: TH (except those that secrete IL-2), T 
suppressor (Ts) and T delayed hypersensitivity (ToHl cells (Fishbein et 
al., 1983; Palacios, 1982; Farrar et al., 1982). In mice, enhancement of 
natural killer (NK) cell cytoxicity activity by the addition of IL-2 was 
observed (Henney et al., 1981). Follow-up studies, using cultures free 
of gamma interferon (IFN-Y), demonstrated IL-2 induced IFN-Y production 
by both TH and CTL cells which, inturn, promoted NK activity (Weigent et 
al., 1983; Kasahara et al., 1983; Trinchieri et al., 1984). In addition 
to the enhancement of T cell proliferation and activity, IL-2 was able to 
substitute for TH cells in T cell-dependent antibody formation (Farrar et 
al., 1978; Farrar et al., 1982). However, the mechanism of B cell 
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activation by IL-2 is unclear. It has been demonstrated that activated B 
cells grow poorly in IL-2 containing supernatants, B cells and B cell 
blasts do not absorb IL-2 activity in the murine system, and clonal 
expansion of hapten-specific B cells required soluble factors distinct 
from IL-2 (Smith and Ruscetti, 1981; Leibson et al., 1981; Pike et al., 
1982). Despite these observations, other studies have suggested that 
activated B cells express receptors, similar to those of activated T 
cells, which were able to bind to IL-2 and promoted B cell proliferation 
(Zubler et al., 1984; Mingari et al., 1984; Muraguchi et al., 1985). 
There was also evidence that IL-2 promotes Ia expression on resting B 
cells which increased the antibody forming cell's ability to bind to 
macrophages thus enhancing the antigen presenting phase of antibody 
formation (Roehm et al., 1984). 
Therefore, IL-2 has been demonstrated to play a pivotal role in the 
proliferation of cells involved in both the cell-mediated and humoral 
immune responses. In addition, it was shown to augment the production of 
IFN-Y, which promotes NK activity during viral infections. Moreover, 
the amount of proliferation of these cells has been shown to be mediated 
by the levels of IL-2 present (Gillis et al., 1978). 
Regulation of IL-2 
As described earlier (Figure 1), activation by antigen or lectin is 
necessary for production of and response to IL-2. Once these cells have 
been activated, however, the extent of their proliferation has been shown 
to be dependent on the levels of IL-2 present (Gillis et al., 1978; Smith 
et al., 1980). This concept, regulation by an antigen-nonspecific factor 
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(IL-2) of T cell clonal expansion (which is antigen specific), presented 
an enigma to immunologists until the IL-2 receptor system was realized 
(Smith, 1984). The influence of suppressor factors on IL-2 production 
has provided useful information in defining the role of IL-2 in the 
maintenance of immunological homeostasis (for review, see Asherson et 
al., 1986). Additional studies have also shown that genetic regulation 
of IL-2 and its receptor were a factor in the levels of T cell 
proliferation (Kawamura et al., 1986; Wofsy et al., 1981). 
The IL-2 receptor has been described as having high- and low-
affinity binding sites (Robb et al., 1984b). The high affinity receptor 
(Kd ~ 5-20 pM) was shown to be expressed on T cells following activation 
by antigen or lectin and was able to promote DNA synthesis resulting in T 
cell proliferation following induction by IL-2 (Robb et al., l984a; Smith 
and Cantrell, 1985; Reske-Kunz et al., 1986). Conversely, T cell 
activation by lectin or antigen did not induce proliferation via the low-
affinity receptor; its physiological role has not been determined at this 
time (Smith and Cantrell, 1985; Reske-Kunz et al., 1986). Binding 
studies, using AMT-13 (monoclonal antibody to the murine IL-2 receptor) 
and anti-Tac (monoclonal antibody to the human IL-2 receptor), have shown 
that both the high- and low-affinity receptors interacted with these 
monoclonal antibodies resulting in the decreased availability of the IL-2 
binding sites (Osawa and Diamantstein, 1985; Robb et al., l984a). 
However, the most remarkable observation that arose from these studies 
was that IL-2 regulated its own receptor (Robb et al., 1984a; Smith and 
Cantrell, 1985; Reske-Kunz et al., 1986). The effect of IL-2 on its 
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receptor has been a subject of controversy. 
Smith and Cantrell (1985) used purified IL-2 with preactivated human 
peripheral blood mononuclear cells and observed that IL-2 lowers the 
number of high-affinity binding sites. They suggested that regulation by 
IL-2 provided a "fail-safe" mechanism of control over T cell clonal 
expansion. Because high-affinity IL-2 receptors were only expressed 
after antigen activation, they believed the presence of IL-2 insured that 
the number of antigen-specific activated T cells decreased as the antigen 
was being cleared. 
Conversely, Reske-Kunz et al. (1986), using recombinant IL-2 in 
cloned T cell cultures, found that IL-2 upregulates the levels of high-
affinity receptors. The authors suggested that IL-2 played a role in the 
amplification and prolonged expression of IL-2 receptors. Therefore, 
high levels of activated T cells could be maintained following antigenic 
challenge. This model was supported by other studies which demonstrated 
that IL-2 upregulated IL-2 receptor expression and continued presence of 
the antigen was not required for the continued proliferation of progeny 
cells (Malek and Ashwell, 1985; Reske-Kunz et al., 1984). Reske-Kunz et 
al. (1986) further postulated that clonal expansion continued until 
contraregulatory mechanisms began to act. 
Asherson et al. (1986) have described a contramechanism which 
maintained the balance between suppression and immunity which was based 
on the level of IL-2 present. They have suggested that a helper-
suppressor circuit existed in which suppressor function dominated when 
IL-2 was rate limiting, but helper function dominated when abundant IL-2 
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was present. Therefore, as the level of IL-2 was decreased due to the 
absorption by the responding T cells, Ts cells (which required less IL-2 
to be activated or had a higher affinity for IL-2) removed the remaining 
IL-2, thus polyclonal activation was terminated. 
Many suppressor factors have been reported which influence different 
phases of IL-2-dependent T cell proliferation (for review, see Asherson 
et al., 1986). Because the amplification of IL-2 production was IL-1 
dependent, inhibitors of IL-1 (e.g., glucocorticoids) consequently 
inhibited IL-2 production (Smith et al., 1980). IL-2 was shown to be 
inhibited by high levels of prostaglandin E2 released by macrophages 
(Rappaport and Dodge, 1982). A number of reports have described soluble 
factors contained in supernatants of Con A stimulated-lymphocytes that 
reduced the production of IL-2, but did not block the interaction between 
IL-2 and its receptor (Kramer and Koszinowski, 1982; Malkovsky et al., 
1982; Kromer et al., 1985). Immunosuppressive drugs, namely, 
cyclosporin A and dexamethasone also inhibited IL-2 production (Larsson, 
1980). However, at low concentrations, cyclosporin A acted by inhibiting 
the responsiveness to IL-2. Recently, another soluble factor released by 
Con A stimulated rat Ts cells has been described that inhibited DNA 
synthesis of proliferating T cells which resulted in failure in 
production of and response to IL-2 (Chiba et al., 1985). Therefore, 
influence at the macrophage, the TH cell, and/or the responding T cell 
level has been demonstrated. 
Genetic regulation of IL-2 production and of expression of the IL-2 
receptor has also been demonstrated. Wofsy et al. (1981) have shown that 
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the murine lJl.r gene was responsible for decreased production of IL-2 in 
mice that possessed this gene. Kawamura et al. (1986) have shown that 
there is genetic regulation of IL-2 receptor levels in mice. 
The lJl.r gene of MRL/MP-l.Jl.r/l.Jl.r mice has been shown be the cause 
lymphadenopathy, antibody production to nucleic acids and immune complex 
glomerulonephritis (which are characteristics of systemic lupus 
erythmatosis, SLE) in mice (Grant, 1982). To determine the effect of 
this gene on IL-2 production, Wofsy et al. (1981) transfered the lJl.r gene 
into C57BL/6J mice. They found that Con A activated T cells of mice that 
were homozygous for the lJl.r gene have a 10-fold decrease in their ability 
to produce IL-2 compared to the control mice (C57BL/6J-l.Jl.r-/lil.r- or 
C57BL/6J-l.Jl.r+/l.Jl.r-). Furthermore, the spleen cells from the mice 
containing the lJl.r gene had a 100-fold decrease in their ability to 
respond to IL-2 following Con A stimulation in vitro. 
In a recent study, Kawamura et al. (1986} have provided the first 
evidence of genetic regulation of IL-2 receptor expression in 
unstimulated murine splenic T cells. They found that there was a 2-fold 
increase of IL-2 receptor expression in Bl0.D2 mice compared to DBA/2 or 
BALB/c mice. The genetic control of receptor expression was not Mls-
(mixed-lymphocyte stimulating locus, located on chromosome 1) or H-2-
linked. There appeared to be more than one gene responsible. One of the 
genes has been mapped to chromosome 7, while another has been tentatively 
placed on chromosome 4. 
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Biochemical and Molecular Properties of IL-2 
The IL-2 Assay 
The quick and quantitative microassay for detection of IL-2 activity 
developed by Gillis et al. (1978) used culture supernatants from mitogen-
stimulated murine or rat spleen cells. The IL-2 activity from these 
supernatants was measured by its ability to promote the proliferation of 
murine (C57BL/6) tumor specific cytotoxic T lymphocyte lines (CTLL 1 and 
CTLL 2), which was measured by the incorporation of 3H-thymidine. The 
mitogens used to stimulate the spleen cells included: Con A, PHA, 
Pokeweed mitogen (PWM) and Escherichia coli lipopolysaccharide (LPS). 
They found that the Con A-stimulated spleen cells contained the greatest 
amount of IL-2 activity followed by PHA, PWM and LPS, respectively. In 
addition, they found that a 48 hour incubation period with 5 ug/ml Con A 
produced the highest level of IL-2 activity. 
Larsson et al. (1980b) demonstrated that accessory cells were 
necessary for mitogen-dependent T cell activation. In a recent study, 
however, Roosnek et al. (1985a) demonstrated that IL-1 with phorbol 
myristate acetate (PMA) abolishes the need for accessory cells to 
activate human T cells in vitro. In addition, they demonstrated that 
thiols, 2-mercaptoethanol (2-ME) and reduced glutathione (GSH), which 
provided sulfhydral groups, substituted for accessory cells after the 
accessory cells have been depleted from the medium (Roosnek et al., 
1985b). By varying the culture conditions, Roosnek et al. (1985b) have 
defined the parameters by which mitogen-dependent T cell proliferation 
promoted IL-2 production in vitro. At low concentrations of Con A (I-5 
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ug/ml), accessory cells were necessary for IL-2 production. At moderate 
(7.5-20 ug/ml) or high (greater than 20 ug/ml) concentrations of Con A, 
however, thiols or the Con A alone, respectively, were able to promote 
IL-2 production without the presence of accessory cells. 
Another consideration of the assay was the choice of lectin used to 
activate the T cells to produce IL-2. Yamakido et al. (1985) compared 
the levels of IL-2 produced from human peripheral blood lymphocytes 
following activation by PHA-M (mucopolysaccharide), PHA-P (protein), 
Con A, PWM (polyclonal activator of both T and B cells) or LPS 
(polyclonal activator of B cells). They found that the IL-2 production 
was greatest from cells stimulated by PHA-P and PHA-M followed by Con A, 
PWM, and LPS, respectively. It should be noted that a 30-fold greater 
concentration of PHA-M was required to achieve the same levels of IL-2 
production as PHA-P. The IL-2 levels achieved by stimulation with PHA-M, 
PHA-P, Con A and PWM were high compared to the levels obtained from LPS 
stimulation. The results agree with those of Gillis et al. (1978) who 
also found that the B cell polyclonal activator, LPS, would not promote 
IL-2 production. 
After the development of the assay, it was immediately apparent to 
investigators in the field that the assay needed to be standardized so 
the results could be compared (Aarden et al., 1979) .. Consequently, a 
number of laboratories agreed to prepare and provide partially purified 
IL-2 samples with defined units of biological activity to be used as 
standards. One unit of IL-2 activity was defined as the log of the 
dilution that corresponded to 50% of the maximal proliferation of the 
17 
standard (for review, see Gillis et al., 1978). The IL-2 activity of an 
unknown test sample was then calculated by dividing the log dilution 
at 50% maximal proliferation of the unknown by the standard. 
The assay developed by Gillis et al. (1978) to detect the levels of 
mammalian IL-2 activity was not effective, however, in detecting avian 
IL-2 activity until a number of modifications were made (Kromer et al., 
1984). First, cloned lines of murine lymphocytes, such as those used by 
Gillis and his associates, did not respond to avian IL-2 (Schauenstein et 
al., 1982). This meant that a heterogeneous population of avian 
splenocytes or peripheral blood lymphocytes would have to be used instead 
of the homogeneous lines available to investigators studying mammalian 
IL-2. The use of Percoll differential centrifugation has permitted the 
separation of the mitogen-stimulated lymphoblasts from the rest of the 
non-stimulated and non-T cells that may be present (Kurnick et al., 
1979). Second, mitogen-red blood cell complexes (MRC) instead of free 
mitogen have been used to stimulate avian IL-2 producing lymphocytes. 
This modification stemmed from an observation by Powell (1980) who 
reported that mitogen-induced proliferation of chicken lymphocytes was 
enhanced by the addition of red blood cells. Kromer et al. (1984) 
observed that there was a 3-fold increase of proliferation when the MRCs 
were used, compared to the same concentration of free mitogen. Finally, 
crude supernatants from lectin-activated chicken T cells had to be used 
as standards instead of the purified preparations avaialible to 
researchers of mammalian IL-2 (Frederickson and Sharma, 1985). 
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Molecular and biochemical properties of ll-2 
The development of the microassay for ll-2 enhanced the ability of 
immunologists to biochemically characterize ll-2 (Gillis et al., 1982). 
Human, mouse, and bovine ll-2 have been studied extensively and were 
found to be 14,000-25,000 molecular weight glycoproteins (mature mouse 
ll-2 existed as a 30,000 molecular weight homodimer) with isoelectric 
points (pl) between 4.4 and 7.8 (Mier and Gallo, 1982; Gillis et al., 
1982; Watson et al., 1979; Cerretti et al., 1986). Chicken ll-2 was 
found to have a comparable molecular weight of 13,000 daltons and a pl of 
5.9 (Schnetzler et al., 1983; Vainio et al., 1986). 
The assay to detect functionally active ll-2 as well as molecular 
cloning techniques were employed to clone and sequence the ll-2 gene (for 
review, see Smith, 1984). The genes of human, mouse and bovine ll-2 were 
found to code for mature polypeptides of 133, 149 and 135 amino acids, 
respectively (Holbrook et al., 1984; Kashima et al., 1985; Reeves et al., 
1986; Cerretti et al., 1986). The calculated molecular weights of human, 
mouse and bovine ll-2 were 15,420.5, 17,233.5 and 15,464 daltons, 
respectively. The calculated molecular weights compared to the weights 
initially reported using electrophoretic analysis of purified 
preparations. The heterogeneity of size and charge originally observed 
from electrophoretic analysis of each species' ll-2 has been attributed 
to post-translational modification in the attachment of the carbohydrate 
(Robb et al., 1981; Robb et al., 1984b). 
The gene for human ll-2 has been shown to exist as a single copy 
based on restriction endonuclease digestion followed by Southern blotting 
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analysis of genomic clones of IL-2 genes from normal and malignant 
lymphoid cells (Holbrook et al., 1984). The 4 exons and intravening 
sequences consisted of 4,930 base pairs. The amino acid sequence 
homology between mouse and human, human and bovine, or mouse and bovine 
was 60%, 65%, or 50%, respectively (Cerretti et al., 1986). 
The similarity of sizes, charges and amino acid sequences of IL-2 
between different mammalian species has permitted some degree of 
interspecies activity (Cerretti et al., 1986). Human IL-2 induced the 
proliferation of both murine and bovine T cell lines (Gillis et al., 
1982; Brown and Grab, 1985). However, bovine IL-2 did not induce the 
proliferation of murine IL-2 dependent T cell lines (Cerretti et al., 
1986). Although the size and charge of chicken IL-2 was comparable to 
mammalian IL-2, interspecies activity did not take place (Schauenstein et 
al., 1982; Vainio et al., 1986). Vainio et al. (1986) suggested that the 
lack of stimulatory effects between chicken and mammalian IL-2 
demonstrated the long phylogenic distance between mammals and birds. 
They postulated that the study of the mechanism of IL-2 activity in 
chicken T cells would be a good starting point in studying the evolution 
of the molecules that mediate the T cell response. 
IL-2 and Immune Disorders 
Decreased production of and response to IL-2 has been reported for a 
variety of infectious disease systems. These included diseases resulting 
from Trypanosoma cruzi (Chaga's disease), Plasmodium berghei (malaria), 
Histoplasma capsulatum (systemic mycoses), Mycobacterium leprae (leprosy) 
and Leishmania major (oriental sore) infections (Harel-Bellan et al., 
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1983; Lelchuk et al., 1984; Watson et al., 1985; Mohagheghpour et al., 
1985; Cillari et al., 1986). Many primary (present at birth) as well as 
secondary (acquired) immunodeficiency diseases which have led to an 
autoimmune state have also exhibited low levels of IL-2 production (for a 
review see Kromer et al., 1986; Welte and Mertelsmann, 1985). In 
addition, low levels of IL-2 have been observed in young and old 
individuals, T cell malignancies and in the state of immunological 
tolerance (Gilman et al., 1982; Smith, 1984; Malkovsky et al., 1985). 
Smith and Talal (1982) have suggested that IL-2 played a role in 
immunological homeostasis. Their model demonstrated that a certain level 
of IL-2 had to be present to augment the activity of cells that remove 
virally or chemically altered cells. Therefore a paucity of IL-2 in 
autoimmune or lymphoproliferative diseases had permitted the survival of 
altered or diseased cells. 
Recently, the notion that low IL-2 levels were responsible for 
autoimmunity has been challenged (Kromer et al., 1986). Hefeneider et 
al. (1984) were the first to suggest high levels of IL-2 production were 
responsible for autoimmunity. This theory has been supported by a number 
of observations. First, some autoimmune diseases (e.g., spontaneous 
autoimmune thyroiditis) produced high levels of IL-2 compared to age and 
MHC-matched controls (Schauenstein et al., 1985). Second, the defect in 
Con A-induced IL-2 production originally reported in autoimmune mice was 
corrected in vitro by the addition of a second mitogen, phorbol myristate 
acetate (Santoro et al., 1983). Finally, limiting dilution analysis has 
shown that autoimmune mice had normal to increased numbers of IL-2 
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producing cells, but their frequencies were lower (Hefeneider et al., 
1984; Miller and Stutman, 1982). Hefeneider et al. (1984) demonstrated 
that sites of the immune response (spleen and mesenteric lymph nodes) 
contained normal to increased numbers of IL-2 producing cells as well as 
an extremely high level of non-IL-2 producing cells. They postulated 
that the paucity of IL-2 production was due to a "crowding" effect 
created by the adsorption and subsequent proliferation by the non-IL-2 
producing cells of the IL-2 present. Therefore, the paucity of IL-2 
production was not the mechanism responsible for the autoimmune state, 
rather, hyperproduction of IL-2 had enhanced the proliferation of 
autoreactive lymphocytes (Kromer et al., 1986). 
The model of hyperproduction of IL-2 was also supported in age-
related immune dysfunctions (Kromer et al., 1985). In immunocompetent 
individuals, immunological homeostasis was maintained by the balance 
between IL-2 production and suppressor factors (Asherson et al., 1986). 
Globerson et al. (1982) have shown that inhibitory regulation declined 
with age. Kromer et al. (1985) postulated that the decreased levels of 
suppressor factors observed in aged individuals have permitted high 
levels of IL-2 production; thus, "forbidden" immune reactions were 
allowed to take place. Malkovsky et al. (1985) have suggested that 
suppressor factors of IL-2 in young individuals have created an 
immunological tolerant state permitting the distinction of "self" and 
"non-self" antigens. In addition, they reported that immunological 
tolerance was alleviated by the addition of exogeneous IL-2. 
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Hyperproduction of IL-2 due to the absence of host suppressor 
factors, however, could not account for low levels of IL-2 production 
observed in all autoimmune states, such as Nezelof syndrome and severe 
combined immunodeficiency disease (Kromer et al., 1986; Flomenberg et 
al., 1983; Lopez-Botet et al., 1982). Moreover, other immune disorders 
have displayed their own mechanism of inhibiting IL-2 dependent immunity. 
The infectious agents of 1,. cruzi, £..,_ berghei, !::!..,_ capsulatum and 11,_ 
leprae inhibited the production of IL-2 by suppressing the macrophages' 
ability to produce IL-1 (Harel-Bellan et al., 1983; Lelchuk et al., 1984; 
Watson et al., 1985; Mohagheghpour et al., 1984). The progression of 
leishmaniasis was due to the hypersecretion of prostaglandin E2 by 
macrophages which inhibited the production of IL-2 (Cillari et al., 
1986). Jenski and Ledford (1985) reported that MCDV-12 (a transplantable 
Rauscher murine leukemia retrovirus) tumors secreted their own IL-2 
suppressor which inhibited IL-2 dependent immunity in close proximity to 
the tumor. In addition, Greene et al. (1986) have shown that the 
insertion of the trans-activator gene of the human T-lymphotrophic virus 
type II (HTLV-II) into some human leukemic T cell lines induced both IL-2 
and IL-2 receptor gene expression. 
Therefore, a number of different immune disorders which affected IL-
2 production have been reported. In addition, the mechanisms inhibiting 
IL-2 dependent immunity differed depending on the nature of the disorder. 
Because of the various methods in which immune disorders can affect 
immunological homeostasis, Kromer et al. (1986) have suggested caution 
when considering IL-2 as a therapeutic agent. 
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Genetic Control of the Immune Response in the Chicken 
Knowledge of the genetic control of the immune response in the avian 
immune system has not approached the level currently known of the 
mammalian systems. As a result, studies of the avian immune system have 
relied on models developed primarily within the mammalian systems. The 
genetic control of the immune response can simply be divided into two 
levels (for a review, see Clark, 1983). One level of genetic control 
involves the interaction and recognition of class I and II MHC gene 
products. The other level involves the contributions of non-MHC gene 
products in antigen recognition as well as complementing the immune 
response. 
Studies of the genetic control of the avian immune system have 
primarily focused on MHC genetic control. The MHC of the chicken was 
discovered in 1961 when it was shown that the serologically-detected Ea-B 
blood group locus was associated with the ability to reject grafts 
(Schierman and Nordskog, 1961). Later, Miggiano et al. (1974) showed 
that the Ea-B locus was also associated with the mixed lymphocyte 
reaction. Based on the studies, it was suggested that the B system was 
the phylogenic homolog of the murine H-2 and human HLA (Pazderka et al., 
1975). Hence, the chicken MHC has been denoted as the B complex. 
The requirement for MHC class I and II interaction and recognition 
in the immune response of mammalian species has been well-documented (for 
a review, see Clark, 1983). Similar evidence, however, was not provided 
within avian species until recently. Maccubin and Schierman (1986) have 
provided the first evidence of avian MHC restriction of cellular 
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cytotoxicity as first described by Zinkernagel and Doherty (1974). In 
addition, Vainio et al. (1984) used MHC recombinant lines for adoptive 
transfer of bursal cells to demonstrate that genes located in the class 
II region of the chicken encode the products controlling T-B cell 
interactions. 
The MHC of the chicken has been shown to encode for at least three 
different MHC antigens (Pink et al., 1977). One antigen is the class I 
antigen, denoted as B-F in the chicken system, that is present on both 
leukocytes and erythrocytes and is homologous to the murine H2-K and H-20 
antigens. Another is the class II antigen, denoted as B-L, that is 
present on some leukocytes and is homologous to the murine I region. The 
chicken MHC also encodes for a class IV antigen, denoted as B-G, that is 
found only on erythrocytes. There is no known mammalian homolog for the 
class IV antigen. 
As stated previously, non-MHC genetic control has also been shown to 
effect the immune response. Non-MHC genetic control has been 
demonstrated at two levels in the chicken immune system. One level 
involves the ability of the chicken to genetically recognize and respond 
to an antigen. An example of this level of genetic control in the 
chicken was demonstrated by Gebriel and Nordskog (1983) when they showed 
that tv loci, that codes for cellular resistance to Rous sarcoma virus 
(RSV), mapped outside the MHC. Another level of genetic control involves 
the role these genes play in the immune response. Linkage of the abilty 
to respond to RSV-induced tumors to the MHC has been well-documented. 
(Schierman et al., 1977; Gebriel and Nordskog, 1983). But, the 
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influences of non-MHC gene loci have also been shown to be important in 
the control of RSV-induced tumor response (Cutting et al., 1981; Gilmour 
et al., 1983). In addition, non-MHC as well as MHC genetic control has 
been demonstrated in the ability to respond to Con A (Miggiano et al., 
1976; Pink and Miggiano, 1977; Morrow and Abplanalp, 1981). 
The study of the genetic control of the immune response in the 
chicken, therefore, has attempted to employ models already established 
for mammalian systems. Most of these models for the genetic control of 
the immune response in mammalian species have also been valid for 
chickens. But, in some instances (e.g., the lack of a mammalian MHC 
class IV homolog) the genetic models have not directly applied. Because 
of the phylogenic distance between aves and mammals, differences in the 
genetic control of the immune response may be present. 
Summary 
IL-2 is defined as a soluble immunoenhancing factor released 
primarily by lectin- or antigen-activated TH cells in the presence of Il-
l. IL-2 plays a pivotal role in the augmentation of T cell responses, 
IFN-Y production and NK activity, and may influence T dependent B cell 
responses. The regulation of IL-2 production and activity is influenced 
by the inducing antigen, by suppressor factors, by genotype, and by IL-2 
itself. The balance between suppressor factors and IL-2 production 
dictate immunological homeostasis in IL-2-dependent immune responses. 
Many immune disorders occur as a result of the imbalance between the 
levels of IL-2 production and suppression. 
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The assay to detect IL-2 activity, which is based on the ability of 
supernatants from lectin-activated mononuclear cells to support the 
growth of lectin-activated T cells in vitro, has been instrumental in 
characterizing IL-2. Although the sizes and charges of avian and 
mammalian IL-2 are similar, interspecies activity does not occur. Due to 
the phylogenic distance between avian and mammalian species, the study of 
chicken IL-2 may be an initial step in analyzing the evolution of the 
molecules involved in T cell proliferation. Moreover, since the ability 
to recognize and respond to a specific antigenic challenge is genetically 
controlled, the study of the genetic control of factors governing immune 
response in the chicken may provide some insight into the evolution of 
genetic regulation of the immune response. 
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MATERIALS AND METHODS 
Description of the Lines 
One partially inbred line (SI) and eight inbred lines of chickens 
(Gallus domesticus) were used in this study. The birds were randomly 
housed in IO-ft.2 floor pens with fifteen to twenty birds per pen. The 
birds of each genotype (genetically distinct groups) within the SI or 
inbred lines were randomly sampled at each collection time because it was 
not possible to obtain a blood sample from each genotype during each 
sampling session. In addition, equal numbers of samples from each of the 
genotypes were gathered during each week to insure that the weekly 
sampling effects would not favor one genotype over another. 
Inbred lines 
Inbred lines of Leghorn, Spanish, and Fayoumi breeds, with 
inbreeding coefficients ranging from 8I to 97%, were used in this study 
(Gebriel and Nordskog, 1983). The eight inbred lines each have one to 
three of 8 different MHC alleles fixed within their genomes (Table I). 
Major histocompatibility type was determined serologically. Schierman 
and Nordskog (1961) showed that the serologically detected Ea-8 blood 
group locus, which controls the expression of specific erythrocyte 
antigens, also serves as an MHC marker. Hence, the chicken MHC has been 
denoted as the B complex. For convenience, the Ea-BX allele has been 
expressed as Bx (Altman and Katz, I979). The BS.I, Bl5.l and B21.l MHC 
alleles have similar, but not identical, serological properties to the 
standard B5, BIS and B21, respectively (Gebriel and Nordskog, 1983). All 
inbred lines have been closed breeding populations for at least 20 years. 
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Lines 8, 9, and 19 are highly (approximately 91, 89, and 90%, 
respectively) inbred Leghorn lines possessing the BlS.1 MHC allele. The 
Bl3 MHC allele is also deliberately maintained within line 19. The lines 
have a common ancestory originating from early inbred lines established 
at Iowa State University (formerly Iowa State College) in the 1930s 
(Stephenson, 1949; Somes, 1984). Line 9, however, was briefly crossed 
with the Spanish line and later backcrossed to line 9 (Somes, 1984). 
Table 1. Iowa State University inbred lines and their major 
histocompatibility haplotypes 
Wright's coefficient 
Year of of inbreeding 
Line Breed origin (percent) 1978 MHC all el ea 
8 Leghorn pre1940 91 BIS.I 
9 Leghorn prel940 89 BIS.I 
19 Leghorn pre1940 90 Bl3, BIS.I 
GH Leghorn 19S4 90 Bl, Bl3, Bl S. I 
GHs Leghorn 196S 9S B6, Bl3 
HN Leghorn 19S4 97 Bl2, BIS 
M Fayoumi 19S4 81 BS.I, BIS.I 
Sp Spanish 19S4 92 B21. I 
aBx designates the BX MHC allele. 
Line GH is a highly (approximately 90%) inbred White Leghorn line 
that is comprised of three sublines. Each subline is fixed for either 
the Bl, Bl3, or BIS.I MHC allele. The line originated from a commercial 
line developed by Ghostley Poultry Breeders (Somes, 1984). In 19S8, a GH 
29 
female was accidently mated to an HN male producing Fr progeny (Lee, 
1980). Subsequent generations have been derived from F2 and HN males to 
GH female backcross progeny (Schierman, 1962). The GH line originally 
segregated randomly for the MHC alleles B13 and BIS.I. In 1974, the Bl 
allele was transfered into the line and all three alleles have been 
deliberately maintained in the line since. 
Line GHs is another highly (approximately 9S%) inbred White Leghorn 
line that has the B6 or B13 MHC allele fixed within each of its two 
sublines. In I96S, Dr. L. W. Schierman brought a sample of the GH line 
to the New York Medical College (Lee, 1980). Ten years later, a sample 
was returned to Iowa State University. Subsequent MHC-typing revealed 
that the birds maintained the MHC alleles B6 and BI3 (Lee, 1980). GHs-B6 
and GHs-BI3 will be referred to as G-B2 and G-BI, respectively, and the 
GHs line as the G line, to be consistent with the literature from other 
investigators that use this line. 
Line HN is also a highly (approximately 97%) inbred White Leghorn 
line. Line HN has the BIS and BI2 MHC allele fixed within separate 
sublines. The line was obtained as a "pure" Kimber line from Heisdorf 
and Nelson, Inc. (Somes, I984). 
Lines M and Sp are the other two highly (approximately 8I and 92%, 
respectively) inbred lines. Line M is a Fayoumi line that is composed of 
two sublines that are fixed for either the BS.I and BIS.I MHC alleles. 
Line Sp is a Spanish (Castellana negra) line that is fixed for the B2I.I 
MHC allele. The Fayoumi breed was imported from Egypt to Iowa State 
University in I949. Nordskog and Phillips (I960) have shown that line M 
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was particularly resistant to lymphomas. 
A number of genetic studies have been conducted using the inbred 
lines. Singh and Nordskog (1981) reported that the gene frequencies of 
the genetically-controlled polymorphic proteins, alkaline phosphatase, 
esterase I and esterase II, varied among seven of the inbred lines, 
whereas hemoglobin, albumin, and transferrin did not. Using these inbred 
lines, Nordskog and Gebriel (1983) demonstrated that cellular resistance 
to RSV maps outside the MHC whereas RSV regression (i.e., immune 
response) was influenced by the MHC. Lamont and Cowan (1985) found a 
genetic association of the ability of the inbred lines to phagocytize 
colloidal carbon in vivo. Palmer et al. (1981) have demonstrated 
significant line (non-MHC) differences in the immune response to Con A, 
whereas MHC differences were not significant. 
The G line has been widely used by many laboratories to examine 
genetic associations of immune response. The G-81 (GHs-813) genotype has 
been used, in part, in studies which have defined the immune response 
genes to Con A. The immune response to Con A was shown to be controlled 
by two genes, Con Al (Mr-I) gene which was not linked to the MHC and the 
Con A2 gene which was MHC linked (Miggiano et al., 1976; Pink and 
Miggiano, 1977; Morrow and Abplanalp, 1981). Maccubbin and Schierman 
(1986) used the G-8I (GHs-813) and G-82 (GHs-86) genotypes to demonstrate 
MHC-restriction in in vitro cellular cytoxicity to virus-infected cells 
in the chicken, as first shown with mice by Zinkernagel and Doherty 
(1974). 
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SI line 
The SI line is a partially inbred population with an inbreeding 
coefficient of approximately 0.40 (Cheng et al., 1985). The SI line was 
developed in 1965 from two inbred lines of commercial White Leghorns. 
The SI line originally segregated for the MHC alleles Bl, B2, B19, and 
B21 (Cheng, 1985). Prior to 1978, the SI line was randomly bred for the 
MHC alleles Bl, B2, and B19. B21 was intentionally dropped from the 
line. In 1978, the SI line was sublined based on high or low response to 
GAT within each haplotype (Bl or B19) (Pevzner et al., 1978). The B2 
haplotype, with intermediate immune response to GAT, was maintained as a 
control in the SI line (Cheng, 1985). Between 1978 and 1982, the birds 
were randomly bred within each of the 5 sublines. In 1982, nine genetic 
groups (i.e., genotypes) were formed based on high or low immune response 
to GAT, regression or progression of RSV-induced tumors and the MHC 
alleles (Bl and B19), plus the B2 genotype (Gebriel and Nordskog, 1983). 
The nine genotypes have been deliberately segregated and are maintained 
as nine sublines within the SI line (Table 2). 
The SI line is especially important in genetic studies involving MHC 
controlled immune responses because a recombination event has occured 
within the MHC. Benedict et al. (1975) demonstrated that the genetic 
control of the immune response to GAT in the chicken was associated with 
the MHC. Pevzner et al. (1978), using the SI line, have demonstrated 
that the Bl was a low responder whereas the B19 genotype was a high 
responder to GAT. Backcrosses of BIB19 heterozygotes to the BIBI and 
Bl9B19 parental homozygotes, however, produced progeny that typed as Bl 
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or Bl9 and had a high or low response, respectively, to GAT. Pevzner et 
al. suggested that a recombination event had occurred between the immune 
response region and the Ea-B locus which resulted in the high GAT 
response in Bl birds and low response in Bl9 birds. 
Table 2. Genotypes of the Iowa State University partially inbreda 
SI line in 1965, 1978 and 1982 to the present 
1965 
Bl 
Bl9 
B2 
B21 
1978 
Bl-Lo 
Bl9-Hi 
Bl9-Lo 
B2-Int 
(extinct) 
1982-present 
Bl-Hi-RegC 
Bl-Hi-Prog 
Bl-Lo-Reg 
Bl-Lo-Prog 
Bl9-Hi-Reg 
Bl9-Hi-Prog 
Bl9-Lo-Reg 
Bl9-Lo-Prog 
B2-nd-ndd 
(extinct) 
aAverage inbreeding coefficient of the 9 genotypes 
developed in 1982 is approximately 0.40. 
bHi, Lo, and Int represent high, low, and intermediate 
immune response to GAT. 
CReg and Prog denote regression and progression of RSV 
induced tumors. 
dimmune response to GAT and RSV were not determined for 
the B2 genotype in 1982. 
In recent years, the SI line has been utilized to investigate 
genetic association of the immune response to a variety of different 
antigenic challenges. Lamont et al. (1987) have shown that the Bl 
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genotype was significantly more resistant to Pasteurella multocida (the 
etiological agent of fowl cholera) than the 819 genotype, and there was 
not an association with GAT or RSV immune response. The ability to 
phagocytize colloidal carbon in vivo, however, was associated with 
response to RSV induced tumors (Lamont and Cowan, 1985). Steadham et al. 
(1987) demonstrated that resistance to Marek's disease virus (an 
oncogenic herpesvirus) was significantly greater in the Bl than in the 
819 genotype. Moreover, they have shown that high responders to GAT 
within each MHC haplotype were significantly more resistant to Marek's 
disease virus than low responders to GAT. Using an F2 population 
produced from inter se matings of the Sl sublines, however, only Bl-Ir-
GAT-high birds were significantly more resistant to Marek's disease 
virus. 
Experimental Design 
Preliminary study 
The preliminary study was conducted to examine the possibility of 
genetic differences in levels of IL-2 production and to determine the 
repeatability of measurements taken at different times. One haplotype 
(MHC allele) from each of the inbred lines was tested, except the GH line 
in which two haplotypes were used. Therefore, a total of nine genotypes 
(line-MHC allele combinations) were used in the study. One male and 
female of each genotype was used to give a total of 18 birds in the 
study. The birds were divided into three groups of six birds each (Group 
1 = GHs-86, 19-815.1 and HN-815; Group 2 = Sp-821.1, M-85.1 and GH-Bl; 
Group 3 = 8-815.1, 9-815.1 and GH-813). One group was sampled each day. 
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One blood sample was obta1ned from each of the six birds in a group in 
the morning and again in the afternoon. Morning and afternoon blood 
samples were obtained again one week later from each of the birds 
(Table3). 
Table 3. Groups sampled for the preliminary study 
Day 
Time 1 2 3 
morning la 
afternoon 1 3 
8 
1 
1 
9 
2 
2 
10 
3 
3 
aGroup 1 =genotypes GHs-86, 19-815.1, and 
HN-815; 1 male and female per genotype. 
bGroup 2 = genotypes Sp-821.1, M-85.1, and 
GH-81; 1 male and female per genotype. 
cGroup 3 =genotypes 8-815.1, 9-815.1, and 
GH-813; 1 male and female per genotype. 
Inbred lines study 
A survey of the inbred lines was conducted to determine if 
differences in levels of IL-2 production were attributable to MHC or non-
MHC effects. Ten birds, seven to eight months of age, from each of the 
genotypes were examined. Five males and females of each genotype were 
used to determine if sex differences influenced IL-2 production. All the 
blood samples were collected, processed and cultured during a four week 
period. 
SI line study 
The experiment using the Sl line was performed to determine whether 
differences in levels of IL-2 production correlated with allelic and/or 
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immune response differences already observed in the line. Ten birds, six 
to seven months of age) consisting of five males and females from each of 
the nine genotypes in the SI line were tested for levels of IL-2 
production. All the blood samples were collected, processed and cultured 
during a three week period. 
IL-2 Assay Procedure 
The assay used to quantitate the levels of chicken IL-2 production 
in this study was a modification by Frederickson and Sharma (1985) of the 
assay first developed by Kromer et al. (1984). 
Preparation of blood samples 
Ten to twenty milliliters of sterile heparinized (100 IU heparin/ml, 
Sigma No. H-3125, Lot No. 63F-0450) blood were collected in a syringe via 
wing vein or jugular vein puncture. The blood was aliquoted into 3 to 4 
ml volumes in sterile 12x75 mm polystyrene snap-cap tubes (Falcon). 
Slow-spin differential centrifugation (60 x g, IO min., room temperature) 
was performed three times to separate the peripheral blood lymphocytes 
(PBL) from the red blood cells (RBC). The lymphocytes were washed twice 
(600 x g, 5 min., room temperature) in Hank's balanced salt solution 
(HBSS, Gibco). The cells were resuspended in culture medium and live 
cells were counted via trypan blue (Sigma) exclusion using a 
hemacytometer. 
Red blood cells were separated from the remaining PBLs by means of 
centrifugation (700 x g, 15 min., room temperature) through Ficoll-Paque 
(Pharmacia). The RBCs were washed twice in HBSS and resuspended in 
culture medium and counted. 
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Preparation of Con A 
A 10 mg/ml Con A (3X crystallized, Miles 79-003, Lot 79L) stock 
solution was prepared in saturated sodium chloride before each study. 
The working concentration of 2.0 ug/ml Con A was prepared from the stock 
solution. 
Culture conditions 
The culture medium was serum-free RPM! 1640 (Gibco) supplemented 
with L-glutamine (50 mM, Gibco), penicillin (100 U/ml, Gibco) and 
streptomycin (100 ug/ml, Gibco). The cells were cultured at 4o0c in a 
humidified atmosphere containing 5% C02. 
Production of conditioned media (CM) 
The PBLs were cultured at a concentration of 3.3 x 106 cells/ml in 
the presence of 2.0 ug/ml Con A and 2.0 x 106 autologous RBCs/ml in 24-
well tissue culture cluster plates (Costar) at 2 ml volumes. After a 48 
hour incubation period, the supernatants were placed into 50 ml conical 
centrifuge tubes (Corning). The IL-2 containing supernatants (CM) were 
freed from the cells by centrifugation (600 x g, 10 min., room temp.). 
The CM was aliquoted into 1 to 2 ml volumes in sterile vials and stored 
at -20°c until assayed for IL-2 activity. 
Preparation of responder cells 
The responder cells used in the assay were PBLs from line 19-815.1 
birds because they yielded high numbers of responding cells, and thus 
more tests could be performed. The peripheral blood lymphocytes (3.3 x 
106 cells/ml) were incubated in the presence of 2.0 ug/ml Con A. The 
cells were incubated for 72 hours in volumes of 50 ml in 75 cm2 or 
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100 ml in 150 cm2 tissue culture flasks (Corning) standing upright. The 
cells were centrifuged (600 x g, 8 min., room temperature}, resuspended 
and incubated in RPMI 1640 containing 0.05 M methyl a-D-mannopyranoside 
(a-MM, Sigma M-6882) for 15 to 20 minutes at 40°c. The a-MM 
competitively removed the remaining Con A from the cell surface. After 
one wash in HBSS, the population of Con A-activated blast cells were 
enriched by means of density centrifugation (600 x g, 10 min., room 
temperature) using a 20-60-100% discontinuous Percoll (Pharmacia 17-0891-
01, Lot LD 00359) gradient. The interface between the 20-60% layers 
contained the enriched population of lymphocytes that responded to IL-2. 
The blasts were washed twice in HBSS and adjusted to a concentration of 
2.0 x 106 cells/ml in RPMI 1640 containing 0.05 Ma-MM. 
Functional determination of IL-2 activity in CM 
A serial 1:2 dilution of the CM to be tested was performed in 
triplicate in flat bottomed 96-well microtiter plates (Costar) at a 
volume of 100 ul/well. One hundred microliters of the responder cell 
suspension were added to the CM. The control wells consisted of 100 ul 
of cells, CM, or culture media plus an additional 100 ul of culture media 
(RPMI 1640 with a-MM) to bring the total volume to 200 ul. A reference 
standard (CM from GH-815.1, bird # 11129) was used with each test. After 
an 18 hour incubation period at 4o0c in 5% co2, the cells were pulsed for 
5 hours with 1 uCi [methyl-3H] thymidine (3H-Tdr, Amersham TRK.120). The 
cells were collected onto glass fiber filter paper (Whatman 934-AH) using 
a cell harvester (Dynatech Model CH-103). The filter paper containing 
the cells were placed into scintillation vials (Kimble) containing 10 ml 
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of scintillation cocktail (2,5-diphenyloxazole (PPO); 1,4-bis(2-(5-
phenyl-oxazoyl)) benzene (POPOP) in toluene; Fisher). The levels of 
radioactivity were measured by a Packard TRI-CARB 300 scintillation 
counter. 
Mathematical determination of IL-2 activity 
The value for each dilution of the test sample was expressed as the 
mean counts per minute (cpm) of the triplicates after subtraction of the 
background cpm. Background cpm = (cpm cells + medium) + (cpm CM + 
medium) - cpm medium. The cpm values for each dilution were used to plot 
a response regression line plotting cpm versus log %CM for each sample 
(Figure 2). The 50% maximal proliferation value was determined for each 
sample. The 50% value was then transposed to the reference standard 
regression line and the corresponding log %CM was determined. The 50% 
maximal proliferation and its corresponding log %CM was also determined 
for the reference standard. One unit of IL-2 was represented as the 
log %CM giving 50% maximal proliferation of the reference standard. 
Therefore, the units of IL-2 for the test samples were calculated by 
dividing the log %CM of the test sample by the log %CM of the reference 
standard at 50% maximal proliferation (Frederickson and Sharma, 1985). 
Two alternative methods were also used for expressing the data. The 
IL-2 activity was also calculated by dividing the cpm of the test sample 
at 25% CM by the 25% CM of the reference standard. Gross cpm at 25% CM 
was also used as an indication of IL-2 production. 
Figure 2. Determination of levels of IL-2 activity 
I. Determine the cpm corresponding to 50% maximal 
proliferation for the unknowns on their respective 
regression lines. 2. Transpose_ the cpm values to the 
reference standard's regression line. 3. Determine the 
corresponding log %CM. 4. Determine the cpm 
corresponding to 50% maximal proliferation of the 
reference standard. 5. Determine the log %CM 
corresponding to 50% maximal proliferation of the 
reference standard. 6. IL-2 activity is calculated by 
dividing the log %CM of the unknown by the log %CM of the 
reference standard. The IL-2 activity of the reference 
standard is arbitrarily set at 1.00 IL-2 U/ml. 
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Statistical analysis 
The analysis of the preliminary study was conducted using an F-test 
of significance which was divided into three parts. The first part of 
the analysis was a test of significance for differences in levels of IL-2 
production between genotypes and of sex. The second part of the analysis 
tested for significant differences in levels of IL-2 production of 
samples collected in the morning and afternoon for each bird. The third 
part of the analysis tested for significant differences of levels of IL-2 
in samples collected one week apart from the same birds. 
The statistical analysis of the inbred study was approached two 
different ways. An F-test of significance was used to test for 
significant differences of levels of IL-2 production between MHC 
haplotypes, lines, and sexes for all birds used in the study. In 
addition, individual F-tests of significance of differences in levels of 
IL-2 production between MHC haplotype or line differences were conducted 
on available matched data sets because of the many missing cells in the 
previous analysis. 
The SI line was analyzed by an F-test to test for differences in 
levels of IL-2 production between birds that differed at their MHC allele 
(BI and B19), immune response to GAT, and/or their ability to regress RSV 
induced tumors. The B2 birds were not used in the analysis because data 
were not available for their immune response to GAT and RSV. 
The three different methods of calculating levels of IL-2 production 
were compared by determining how well the linear relationship of the IL-2 
values obtained using each method correlated with each other. 
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RESULTS 
Levels of IL-2 production were determined by the relative ability of 
supernatants from Con A-activated PBLs to promote the proliferation of an 
enriched population of Con A-stimulated lymphoblasts in vitro. An 
enriched population of activated lymphoblasts was obtained by 
centrifugation of Con A-stimulated lymphocytes through a Percoll 
discontinuous density gradient to eliminate non-activated cells. The 
efficacy of the Percoll separation procedure in enriching the population 
of lymphoblasts was examined. The cells between the 20% and 60% Percoll 
layers had a significantly (P < 0.01} higher response to IL-2 than did 
Con A-activated cells that were not separated (Table 4). 
Table 4. Effectiveness of the Percoll separation 
procedure in enriching populations of 
Con A-activated lymphoblasts 
Cell Source3 N4 
Non-separated 3 
20-60% Percoll interface 3 
60-100% Percoll interface 3 
3H-Tdr uptakel,2 
(Mean cpm ± SEM) 
12,095 ± 2,1a3b 
18,637 ± 1,ao9a 
1,265 ± 53oc 
lrncorporation of 3H-thymidine in the presence of 
25% conditioned media. 
2Means bearing different letters are significantly 
different, P < 0.01. 
3one hundred microliters containing 2.0 x 106 
cells/ml. 
4Number of birds used from the 19-815.1 
genotype, cultured in triplicate. 
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A reference standard conditioned medium (CM) was used with each 
assay to account for assay-to-assay variation. The reference standard 
was used 47 times throughout the entire study. The average log %CM 
giving 50% maximal proliferation was 1.12 ± 0.08. 
Preliminary Study 
The preliminary study was designed to examine the possibility of 
genetic differences in levels of IL-2 production and to determine whether 
measurements taken at different times were reproducible. The analysis of 
variance for differences between inbred genotypes indicated that there 
were significant differences (P < 0.001) in levels of IL-2 production 
between the nine different genotypes used in the study. Sex differences 
over the nine genotypes, however, did not significantly influence levels 
of IL-2 production (Table 5). 
The IL-2 levels measured from samples collected in the morning and 
afternoon from the same bird did not differ significantly. In addition, 
the influence of sex within each genotype did not significantly influence 
levels of IL-2 production from samples collected in the morning and 
afternoon. 
Differences in levels of IL-2 activity from samples obtained one 
week apart approached significance (0.10 > P > 0.05). In order to 
minimize the effects of week-to-week sampling differences in subsequent 
studies, a collection schedule was devised which insured that equal 
numbers of sample were obtained from each of the genotypes during each 
week of their respective studies. 
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Table 5. Analysis of variance for genetic and sampling 
time differences on levels of IL-2 production 
Source df MS F 
Genotypea 8 2.548 35_39** 
Sex 1 0.004 
Error lb 8 0.072 
Timec 1 0.024 
sex*Tima 1 0.028 
Error 2 16 
Between Weeks 1 0.113 
Error 3f 35 0.031 
Total 71 
aGenotype = line-MHC allele combinations. 
bError 1 = genotype by sex interaction. 
crime = morning or afternoon samples. 
0.75 
0.86 
1.00 
3.69e 
dError 2 = Pooled error from genotype by time 
and sex by genotype by time interactions. 
eo.10 > P > o.o5. 
fError = residual. 
** p < 0.001. 
Therefore, the results of the preliminary study indicated that there 
were genetic influences on levels of IL-2 production. Differences 
between sexes and between morning and afternoon sampling did not 
influence levels of IL-2 activity. As a result, the influence of sex on 
levels of IL-2 production were not considered in the analyses of variance 
of the inbred lines. In addition, differences in levels of IL-2 
production from samples collected in either the morning or afternoon 
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could confidently be considered insignificant. Differences in levels of 
IL-2 production that may occur as a result of weekly sampling were 
accounted for by gathering equal numbers of samples from each of the 
genotypes during each week of the study. 
Inbred Lines Study 
Each of the fourteen genotypes (line-allele combinations) of the 
inbred lines was examined for its ability to produce IL-2. An analysis 
of variance for the overall effects of line and MHC allelic differences 
indicated that both significantly influenced levels of IL-2 production 
(Table 6). Major histocompatibility complex allelic differences were not 
as significant as line differences in influencing levels of IL-2 
production. The influence of sex was not significant, which confirmed 
the results of the preliminary study. Hence, differences between sexes 
were not considered in additional analyses of the inbred lines. 
The mean square (MS) for the line*MHC allele interaction was zero 
because too many data cells were missing from the analysis. There are 
eight different lines and eight MHC alleles within the inbred lines 
(Table 1), therefore an ideal analysis would contain 64 data cells. The 
inbreds lines, however, contain only fourteen different genotypes. As a 
result, only 14 of the 64 data cells were filled in the analysis. 
Moreover, because the effects of line and MHC allele influences were 
confounded in some instances in the analysis (Table 6), it was not valid 
to consider the effects of line differences as being strictly non-MHC 
influences. 
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Table 6. Analysis of variance for the general effects 
of MHC and line differences on levels of 
IL-2 production 
Source df MS F 
Line 5 1.96 21. 79** 
MHC Allele 5 0.23 2.56* 
Sex 1 0.13 1.44 
L ine*MHC Allele 1 0.00 o.ooa 
Error 127 0.09 
Total 139 
aThe F value for the line*MHC allele interaction 
was 0.00 due to the paucity of data cells in the 
analysis. 
* p < 0.05. 
** p < 0.001. 
As indicated earlier, there are eight different lines and eight MHC 
alleles which comprise the 14 genotypes within the inbred lines, 
therefore the analysis should have used 7, 7, and 13 degrees of freedom 
(df), respectively, to test for significance. The analysis, however, 
used 5 df to test significance for both line and MHC allele differences 
and 1 df to test for the line*MHC allele differences because that was the 
number of independent tests that were possible within the 14 data cells 
available. 
Independent (non-confounding) tests for within line (non-MHC) or MHC 
allelic effects on levels of IL-2 production were performed to evaluate 
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the influence of the many missing cells of the analysis of variance for 
general effects. All the independent tests of variance showed that the 
MHC allele did not influence levels of IL-2 production (Table 7). The 
effects of the MHC allele approached significance within three lines, but 
their influence was not as significant as the general effects of the MHC 
allele indicated in Table 6. The independent tests of significance for 
line (non-MHC) influences within a MHC type, demonstrated that the line 
differences significantly influenced levels of IL-2 production (Table 8). 
Thus, the analyses of variance in Table 8 for the effects of line (non-
MHC) on levels of IL-2 production agreed with those of Table 6. 
Therefore, the significance of MHC allele but not line effects were 
affected by the missing data cells from the analysis of variance in Table 
6. Moreover, the non-MHC influences seem to be more important in 
controlling levels of IL-2 production than does the MHC. 
The line-MHC allele interactions could only be tested in paired 
comparisons between the data from the 19-813, 19-815.1, GH-813, and GH-
815.1 genotypes. As shown in Table 9, the influence of the MHC allele 
was not significant whereas line (non-MHC) differences significantly 
influenced levels of IL-2 production. These results agreed with the 
previous analyses as to the significance of line and MHC allele major 
effects. Line by MHC allele interactions were not significant. 
Independent tests of significance for the effects of either line 
(non-MHC) or MHC allelic differences on levels of IL-2 production could 
not incorporate all the different genotypes used from the inbred lines. 
All the genotypes used in the inbred study have been ranked in descending 
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Table 7. Analyses of variance for MHC allele within 
line effects on levels of IL-2 production 
MHC alleles (line)a df MS F 
1. B6, Bl3 (GHs) 1 0.354 3.o9b 
Error 18 O. ll5 
2. Bl3, BIS.I (19) 1 0.005 0.07 
Error 18 0.080 
3. Bl, Bl3, Bl5. l (GH) 2 0.286 2.47C 
Error 27 O. ll6 
4. Bl2, BIS (HN) 1 0.196 2.4lc 
Error 18 0.081 
5. BS.I, BIS.I (M) 1 0.031 0.06 
Error 18 0.055 
aThe source of variation in each analysis is the 
difference between MHC allele effects within a line. 
bo.10 > P > o.os. 
co.2s > P > 0.10. 
Table 8. Analyses of variance of line (non-MHC) within 
MHC allele effects on levels of IL-2 production 
Line (MHC allele)a df MS F 
1. GHs, GH, 19 (Bl3) 2 2.509 is.09** 
Error 27 0.166 
2. 8, 9' 19, GH, M (Bl5.l) 4 1.180 14.42** 
Error 45 0.082 
aThe source of variation in each analysis is the 
difference between line (non-MHC) effects within the MHC 
allele. 
** p < 0.001. 
49 
order based on their mean levels of IL-2 production from ten observations 
per genotype (Table IO). The results in Table 10 support analyses of 
variance presented earlier (Tables 7 and 8) for the inbred study. Lines 
ranked similarly as to their relative levels of IL-2 production, 
regardless of MHC type. The rankings of the genotypes that shared the 
same MHC allele (813 or 815.1), however, were spread throughout the range 
of mean IL-2 U/ml values obtained in the study. The data presented in 
Table 10 affirmed the importance of non-MHC rather than MHC allelic 
effects in influencing levels of IL-2 production in the inbred lines 
tested. 
Table 9. MHC versus non-MHC effects on levels 
of IL-2 production 
MHC allele 
Linea 813 BIS.I X1;ne 
19 I. 72b I. 79 I. 76 
** 
GH 0.89 0.96 0.93 
Xallele 1.31 1.38 
aune represents non-MHC effects. 
bMean IL-2 U/ml from IO observations. 
**p < 0.001 for line effects. 
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Table 10. Mean levels of IL-2 production of 
the inbred genotypes 
Genotypes Meansl 
(Line-MHC allele) (IL-2 U/ml) 
19-815.1 l.79a 
9-815.1 1. 75a, b 
19-813 1. 72a, b 
M-815.1 1.66a, b 
Sp-821.1 l.60a,b,c 
M-85.1 i.5gb,c 
8-815.1 l.42c 
HN-812 i.21d 
HN-815 1.0ld,e 
GH-815.1 0.96e 
GH-813 o.a9e 
GHs-813 o.a1e,f 
GH-81 0.64f,g 
GHs-86 0.549 
lMeans bearing different letters are 
significantly different, P < 0.05. 
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Sl line Study 
The sublines (genotypes) of the partially inbred Sl line were 
examined for their relative abilities to produce IL-2. The B2 genotype 
was not considered in the analysis because data were not available for 
its immune responses to GAT and RSV. 
The analysis of variance of primary factors affecting levels of IL-2 
production in the Sl line (Table 11), indicated that the influence of the 
allele coding for Ea-B type (Bl or Bl9) was highly significant (P < 
0.001). The association between the immune response to GAT and levels of 
IL-2 production approached significance (0.10 > P > 0.05). The effects 
of the ability to regress or progress RSV-induced tumors and of sex, 
however, were not significant. The results of the Sl line study 
contrasted with the inbred lines study which demonstrated that the 
effects of the MHC allele was not significant in the inbred lines. 
The primary factors, their first order and their second order 
interactions were also analyzed to determine whether levels of IL-2 
production differed significantly when the effects of more that one 
factor were considered simultaneously (Table 12). Again, the effects of 
the MHC allele on levels of IL-2 production were significant (P < 0.001). 
Immune response to GAT also significantly (P < 0.05) influenced levels of 
IL-2 production, but to a lesser extent. The first order interaction 
between the MHC allele and immune response to GAT, however, was not 
significant. Although the general effect of RSV response did not 
significantly influence levels of IL-2 production, its first and second 
order interactions were highly significant (P < 0.001). 
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Table 11. Analysis of variance of the primary factors in the 
Sl line affecting levels of IL-2 production 
Source df MS 
MHC allelea 1 25.25 
GATb 1 0.74 
Rsvd 1 0.11 
Sex 1 0.15 
Error 75 0.27 
aMHC alleles Bl or Bl9. 
bHigh or low immune response to GAT. 
co.10 > P > 0.05. 
F 
93.52** 
2.74C 
0.41 
0.70 
dRegression or progression of RSV induced tumors. 
**P < 0.001. 
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Table 12. Analysis of variance of factors affecting levels of 
IL-2 production in the Sl line 
Source df MS F 
MHC all el ea 1 25.22 140.11** 
GATb 1 0.75 4 .16* 
Rsvc 1 0.11 0.61 
Sex 1 0.004 0.02 
MHC all el e*GAT 1 0.06 0.33 
MHC a 11 e 1 e*RSV 1 3.65 20.2a** 
GAT*RSV 1 1.66 9.22** 
MHC allele*GAT*RSV 1 2.20 12.22** 
Error 71 0.18 
aMHC alleles Bl and 819. 
bHigh and low immune response to GAT. 
CRegression and progression of RSV induced tumors. 
* p < 0.05. 
** p < 0.001. 
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Contingency tables were constructed to ascertain the relationships 
between RSV responses and the MHC allele and immune response to GAT on 
levels of IL-2 production (Table 13). The influence of the MHC allele 
and immune response to GAT were significant whereas the effects of the 
immune response to RSV were not, as previously indicated. The first 
order interaction between MHC allele and immune response to GAT shows 
that high responders to GAT within each MHC haplotype produced 
significantly higher levels of IL-2. In addition, the Bl haplotype 
produced significantly higher levels of IL-2 than the Bl9 haplotype 
regardless of GAT response. All interactions between RSV response and 
MHC allele and/or immune response to GAT, however, were inversely 
related. 
Table 14 shows that the genotypes bearing the BIBI allele produced 
higher levels of IL-2 than did birds bearing the Bl9Bl9 allele within the 
SI line. These data agreed with the analysis of variance (Table 12) 
which demonstrated that the influence of the Ea-B allele on levels of IL-
2 production was highly significant. 
Therefore, levels of IL-2 production in the SI line were 
significantly influenced by the genes controlling Ea-B type and immune 
response to GAT (Ir-GAT). The gene controlling regression or progression 
to RSV was not by itself influential in affecting levels of IL-2 
production. The gene controlling the response to RSV induced tumors in 
concert with the genes controlling the immune response to GAT and/or Ea-B 
type, however, significantly influenced levels of IL-2 production. 
55 
Table 13. Contingency tables of the first order interactions 
of factors effecting levels of IL-2 production 
I. MHC allele 
Ir-GAT Bl Bl9 -1GAJ: 
High 2.26a 1.08 1.67 
* 
Low 2.01 0.94 1.48 
x allele 2 .14 ** 1.01 
2. MHC allele 
R-Rs-1 Bl Bl9 k 
Regressor 1.88 1.19 1.54 
Progress or 2.39 0.83 1.61 
Xallele 2 .14 ** I. 01 
3. Ir-GAT 
R-Rs-1 High Low ~ 
Regressor 1. 78 1.29 1.54 
Progressor 1.56 1.66 1.61 
XGAT 1.67 * 1.48 
aMean IL-2 U/ml from 10 individuals, triplicate cultures. 
* . p < 0.05. 
**p < 0. 001. 
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Table 14. Mean levels of IL-2 production of 
the SI sublines (genotypes) 
Genotyp~ 
(Ea-B-Ir-GAT -Rsv3) 
Mean I 
(IL-2 U/ml) 
Bl-Hi-Reg 2.3la 
Bl-Hi-Prog 2.2oa 
Bl-Lo-Reg I.45b 
Bl-Lo-Prog 2.57a 
Bl9-Hi-Reg i.24b,c 
Bl9-Hi-Prog o.93c,d 
Bl9-Lo-Reg i.14b,c 
Bl9-Lo-Prog 0.74d 
!Means bearing different letters are 
significantly different, P < 0.05. 
2High or low immune response to GAT. 
3Regression or progression of RSV-
induced tumors. 
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Comparison of IL-2 Calculation Methods 
Due to the inconsistency in the literature, two alternative methods 
of calculating levels of chicken IL-2 production were compared to the 
method used throughout this study. The values reported and used for 
analysis throughout this study were obtained by dividing the log %CM at 
50% maximal proliferation of the unknown test sample by the log %CM at 
50% maximal proliferation of the reference standard (see materials and 
methods). Alternatively, levels of IL-2 can be expressed as: 1) the 
ratio of the cpm of the test sample at 25% CM to the cpm at 25% CM of the 
reference standard, and 2) gross cpm at 25% CM of the test sample. Each 
of the three methods were used to calculate levels of IL-2 production for 
all the birds used throughout the study. As shown in Table 15, the 
linear relationship of the values (i.e., correlation) obtained using each 
method were highly comparable. Therefore, studies that utilized any of 
these methods could validly compare results with another study that also 
used any the three methods of IL-2 calculation. 
58 
Table 15. Correlations of methods used to calculate 
levels of chicken IL-2 production 
Method ic vs. Method 2d 230 0.94 
Method 1 vs. Method 3e 230 0.89 
Method 2 vs. Method 3 230 0.87 
aN represents a combined total of 230 birds 
obtained from both the inbred and Sl studies. 
br = correlation coefficient. 
cMethod l = IL-2 U/ml values used throughout 
this study which were obtained by dividing the log 
%CM at 50% maximal proliferation of the test sample 
by the log %CM at 50% maximal proliferation of the 
reference standard. 
dMethod 2 = IL-2 U/ml values obtained by 
dividing the cpm of the test sample at 25% CM by 
the cpm of the reference standard at 25% CM. 
eMethod 3 = cpm of the test sample at 25% CM. 
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DISCUSSION 
IL-2 is a soluble immunoenhancing factor that augments T cell 
responses, IFN-Y production, and NK activity and may participate in T-
dependent B cell responses (Farrar et al., 1982). Since IL-2 plays a 
pivotal role in the immune response, a great deal of work has been aimed 
at determining the mechanisms of its action in mammals. Similar efforts, 
however, have not been made in the study of avian IL-2. The paucity of 
reports has been primarily due to the lack of an efficient and effective 
assay to detect avian IL-2 activity. Recently, Kromer et al. (1984) have 
determined the optimal conditions to measure avian IL-2 activity which 
has provided avian immunologists a means of studying avian IL-2. 
The objective of this study was to utilize the avian IL-2 assay to 
determine whether there are genetic influences controlling levels of IL-2 
production. Before the birds were assayed for relative levels of IL-2 
production, the assay was standardized to insure valid comparisons of 
genetically different individuals. In addition, after levels of IL-2 had 
been determined, ability to produce IL-2 was compared with known 
responses to different antigenic challenges. 
Avian IL-2 Assay 
The lymphoproliferative assay used to detect IL-2 activity measures 
the ability of supernatants (containing IL-2) from lectin-activated 
mononuclear cells to promote the proliferation of a responding population 
of lectin-activated lymphocytes in vitro (Gillis et al., 1978). A number 
of modifications have been made to the mammalian IL-2 assay system first 
described by Gillis and his associates so it could be used to detect 
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avian IL-2 (Kromer et al., 1984). First, an enriched population of 
responding lectin-activated chicken lymphocytes are used instead of the 
readily available mammalian cloned cytotoxic T cell lines. Second, 
erythrocytes are added to the lectin-activated mononuclear cells to 
optimize lymphoproliferation. Finally, an avian IL-2 reference standard 
has been used in this study because chicken lymphocytes do not respond to 
mammalian IL-2 (Kromer et al., 1984; Vainio et al., 1986). 
Ideally, an assay for IL-2 activity would use supernatants that 
contain only IL-2 and the responding cell population would be comprised 
solely of CTLs. The assay system used in this study, however, measures 
the ability of crude preparations of mitogen-stimulated PBL supernatants 
to promote the proliferation of an enriched population of lymphoblasts. 
Because both the supernatants and responding cell populations are not 
homogeneous, the assay can only provide an indirect estimation of IL-2 
activity. Peripheral blood lymphocyte cultures are composed of a 
heterogeneous population of cells including T cells, B cells, 
macrophages, and polymorphonuclear leukocytes. These cell populations 
have the capability of producing other immunoenhancing factors that also 
augment lymphoproliferation (Farrar et al., 1982). The influence of B 
cells is probably negligible since a T cell mitogen, Con A, is used in 
the assay system. Macrophages, however, produce IL-1 which promotes the 
proliferation of the IL-2-producing TH cells (Larsson et al., 1980a). 
Thymocytes also produce IFN-Y that affects lymphoproliferation (Farrar et 
al., 1981). In addition, the responding cell populations contain a 
heterogeneous mixture of lymphoblasts since the Percoll separation 
61 
procedure does not distinguish between lymphocyte subsets. Therefore, 
due to the lack of well-defined supernatants and responding cell 
populations, the assay used in this study measures IL-2 "like" activity 
based on its defined mechanism of action. 
Another source of non-IL-2 associated lymphoproliferation may occur 
as result of residual Con A contained in either the crude supernatant 
preparations or responding cell cultures. The influences of any residual 
Con A that may be present seems unlikely, however, since a-MM is used in 
the assay system. Frederickson and Sharma (1985) have shown that a-MM, a 
competitive inhibitor of Con A, completely abrogates the influence of 
Con A. In this study, the responding lymphocytes were pre-incubated in 
the presence of a-MM, washed twice, and resuspended in media containing 
a-MM. The conditioned media (CM, supernatants containing IL-2) were 
diluted in media containing a-MM. As a result, functional determination 
of IL-2 activity is performed in media containing a-MM. Moreover, 
because the responding cell population is composed of blast cells, 
further proliferation can only be mediated by the addition of IL-2 and 
not by Con A (Smith et al., 1979). 
Responding cell population 
Studies that determine mammalian IL-2 activity traditionally utilize 
a cloned cytotoxic T cell line as their source of responding cells 
(Smith, 1984). Cloned murine or human T cell lines, however, do not 
respond to avian IL-2 (Kromer et al., 1984; Vainio et al., 1986). As a 
result, cultured chicken lymphocyte preparations are used as the source 
of responding cells. The establishment and maintenance of continuous 
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chicken T cell lines have been difficult which have made them hard to 
obtain (Kromer et al., 1984). A Percoll enrichment step has been 
incorporated into the avian IL-2 assay system as means of obtaining 
purified chicken T cell populations. 
The effectiveness of the Percoll separation procedure in enriching 
populations for Con A-activated lymphoblasts was examined (Table 4). The 
results agree with those of Kromer et al. (1984) in that Percoll-enriched 
T cells were more sensitive to IL-2 stimulation that non-separated 
populations of cultures PBLs. This does not exclude the possibility that 
continuous chicken T cell lines may be a more effective means of 
detecting IL-2 activity. 
Recently, Vainio et al. (1986) have generated a long-term chicken T 
cell line that responds better to IL-2 than Con A-activated lymphoblasts. 
They did not, however, enrich their populations of Con A-activated cell 
cultures with Percoll before assaying for IL-2 activity. In addition, 
they used Ficoll-Hypaque to separate PBLs from the whole blood which has 
been shown to yield inconsistent degrees of lymphoproliferation with 
chicken lymphocytes (Maheswaran and Thies, 1975). 
The responding cells used in this assay were obtained from birds of 
the same genotype (line 19-815.1). The lymphocytes from these birds 
yielded the highest number of blast cells following Con A-activation 
which meant more tests could be performed (personal observation; Palmer 
et al., 1981). More importantly, by using responding cells from the same 
genotype, differences in levels of IL-2 production can not be attributed 
to genetic differences of the responding cells. 
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Preparation of crude supernatants 
The primary difference between the avian and mammalian IL-2 assays is 
that the avain IL-2 assay includes chicken RBCs in its lectin-activated 
mononuclear cell cultures as a means of enhancing the production of IL-2. 
Kromer et al. (1984) showed that Con A bound to RBCs increased IL-2 
production by ten-fold. Frederickson (T. L. Frederickson, USDA-ARS, East 
Lansing, Michigan, personal communication) has found that the mere 
addition of RBCs to the culture was equally as effective in enhancing IL-
2 production. He also suggests that RBCs may play a role in enhancing 
IL-2 production by enhancing antigen presentation. Kromer et al. (1984) 
suggest that RBCs may augment antigen presentation by forming complexes 
with the mitogen which enhances the ability of Con A to combine with 
macrophages and T cells than would free mitogen. 
An important consideration of working with chicken RBCs is the fact 
that they possess MHC determinants (Class I) that are shared by 
lymphocytes (Pink et al., 1977). It is therefore possible that antigen 
presentation may also be heightened via MHC recognition. Kromer et al. 
(1984), however, have reported that both MHC-compatible and -incompatible 
RBCs were equally as effective in the assay system. It should be noted 
that their study did not incorporate as many different MHC haplotypes as 
this study did. In addition, their bird populations are comparatively 
small so the genetic diversity would not be as great as it is in this 
study (S. J. Lamont, Department of Animal Science, Iowa State University, 
personal communication). Therefore, to avoid possible influences due to 
MHC-incompatibility, autologous RBCs are used. 
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Reference standard 
Mammalian IL-2 studies traditionally incorporate a reference 
standard of IL-2 activity as a means of accounting for assay-to-assay 
differences and to provide other investigators with a comparative 
indication of the IL-2 levels observed in their study. This study has 
adopted this practice. But in order to utilize a reference standard an 
avian IL-2 reference standard had to be created because mammalian IL-2 
does not augment chicken lymphoproliferation (Kromer et al., 1984). 
The reference standard used for this study was a crude supernatant 
preparation obtained from a culture of one individual GH-815.1 bird. The 
average log %CM giving 50% maximal proliferation of the reference 
standard is 1.12 ± 0.08. The standard deviation is unexpectedly low 
because lymphoproliferative assays traditionally have a high standard 
deviation. The reason for the low standard deviation may be due, in 
part, to the use of a log scale which tends to normalize values. 
Frederickson and Sharma (1985) have reported similar findings. They 
determined that a 6-fold change in the concentration of responder cells 
did not change the %CM that provides 50% maximal proliferation. The 
slopes of the response curves varied, but the log %CM yielding 50% 
maximal proliferation did not. 
As stated previously, each laboratory investigating avian IL-2 
expresses levels of IL-2 activity in a different manner. Schnetzler et 
al. (1983) expressed levels of IL-2 as the log %CM yielding 50% maximal 
proliferation without considering a reference standard. Kromer et al. 
(1984) presented their data in terms of gross cpm of 1251-deoxyuridine 
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incorporation. Frederickson and Sharma (1985) were the first to use a 
reference standard in an avian IL-2 assay system. Recently, Vainio et 
al. (1986) defined I unit of IL-2 as 1/100 of the cpm from a culture 
containing a 1/20 dilution of the CM. Because of the dicotomy of 
approaches used to calculate avian IL-2 levels, a comparison was made to 
determine whether data expressed as raw cpm could be validly compared to 
data that has been adjusted based on a reference standard. In addition, 
a comparison was made between a method that uses the ratio of the cpm of 
the unknown CM to cpm of the reference standard CM and a method that uses 
the ratio of the log %CM of the unknown to the log %CM of the reference 
standard as a means of expressing IL-2 levels. 
As shown in Table 15, there is a high correlation (r = 0.94) between 
calculations that utilize a reference standard. These data agree with 
the observations of Frederickson (personal communication) who now 
utilizes the ratio of the unknown cpm to the cpm of the reference 
standard as a means of expressing IL-2 activity. There was also a high 
positive correlation (r = 0.89, r = 0.87) between the IL-2 calculation 
methods that utilized a reference standard and the method that expressed 
IL-2 levels as raw cpm. It should be emphasized that a positive 
correlation, as seen with these data, indicates that there is a linear 
relationship between the values obtained using each calculation method. 
It does not imply that values obtained in one study can be quantitatively 
compared with values obtained from another study. In order to 
quantitatively compare results obtained from different studies a 
reference standard would have to be used. Based on these results, 
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however, a study utilizing any of the three methods described here, could 
validly compare relative relationships of levels of IL-2 production with 
another study that also used any other of these three methods. 
Analysis of the Genetic Associations of IL-2 Production 
The results of the inbred lines study and Sl line study present an 
enigma as to the source of genetic influence on levels of IL-2 
production. The inbred lines study demonstrates that non-MHC influences 
are greater than MHC influences on levels of IL-2 production. The Sl 
line study, on the other hand, indicates that MHC influences are highly 
significant in affecting levels of IL-2 production. 
The reason for the discrepancy of results between the two studies 
may be a result of the differing genetics of the birds used in each. The 
birds used from the inbred lines study are at least 81% inbred indicating 
that there is little within-line variability in their background (non-
MHC) genes. The Sl line, a partially (approximately 40%) inbred line, 
has more variability in its background genes. In addition, the Sl 
sublines (genotypes) share a common pool of background genes so that each 
subline could posses all the allelic forms of the non-MHC gene(s) 
controlling levels of IL-2 production contained in the gene pool. It is 
conceivable, therefore, that a gene locus coding for a particular level 
of IL-2 production has been fixed within certain of the inbred lines. 
Conversely, there is a smaller chance that one allelic form of this gene 
has been fixed within the Sl line and the non-MHC genes are randomized 
throughout the sublines (genotypes) of the Sl line. The Sl line, 
therefore, is an appropriate genetic model system to investigate MHC-
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associated control whereas the inbred lines are more appropriate for 
examination of non-MHC control. 
Preliminary study 
Before the different genetic stock were assayed to determine their 
relative levels of IL-2 production, a preliminary study was conducted to 
determine if there was evidence for a genetic association of levels of 
IL-2 production. In addition, the influence of sex and time of sampling 
on levels of IL-2 production were also investigated. 
The preliminary study indicated that there are genetic differences 
of levels of IL-2 production between the nine different genotypes 
examined (Table 5). The finding that there appeared to be genetic 
differences was encouraging because it indicated that there may be a 
genetic association of IL-2 production, despite the paucity of reports 
supporting this notion. 
The effect of sex differences was not significant on levels of IL-2 
production (Table 5). The results of the inbred lines study and SI line 
study also supported these data. Therefore, the gene(s) controlling 
levels of IL-2 production does not appear to be associated with sex. 
Differences in levels of IL-2 production that occured as a result of 
obtaining samples in either the morning or afternoon were not 
significant. This indicates that IL-2 production is probably not a 
diurnal event. Since only two different sampling times were tested, it 
is impossible to be sure that there are not cyclic changes in levels of 
IL-2. Nevertheless, differences in levels of IL-2 production from 
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samples obtained in the morning and afternoon were not considered to be 
statistically significant in the inbred lines study and SI line study. 
The effect of week-to-week sampling diffences approached 
significance. As a result, in subsequent studies, equal numbers of 
samples from each of the genotypes were gathered during each week to 
insure that the weekly sampling effects would not favor one genotype over 
another. The fact that weekly sampling effects influenced levels of IL-2 
production suggest that the ability to produce IL-2 is age-related. The 
association of age and levels of IL-2 production is well documented for 
mice, humans, and rats (Gillis et al., 1981; Thoman and Weigle, 1982; 
Gilman et al., 1982). 
Genetic association of IL-2 production in the inbred lines 
As stated previously, the inbred lines are highly inbred, and 
include some sets composed of sublines of birds that are congenic at the 
MHC region. Therefore, it is highly probable that a non-MHC gene locus 
mediating a certain level of IL-2 production has been fixed within each 
of these lines. The analysis of variance of the effects of non-MHC and 
MHC influences on levels of IL-2 production (Tables 7 and 8) strongly 
suggest non-MHC effects are greater than MHC effects. This notion is 
supported by the observation that two lines (Line 19 and Line GH) 
possessing the same MHC type (813 and 815.1) differ significantly in 
their levels of IL-2 production whereas there is not a significant 
difference associated with MHC type differences within the same line 
(Table 9). These data agree with those of Schauenstein et al. (1985) who 
showed that there was not a difference in levels of IL-2 production 
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between Obese strain birds of three different MHC types. 
It should be noted that three of the individual analyses of variance 
for the effects of MHC type (Table 7) show the influence of the MHC to be 
approaching significance. This indicates that MHC effects may also 
influence levels of IL-2 production in the ISU inbred lines, but to a 
lesser degree than non-MHC effects. The possibility of MHC influences on 
levels of IL-2 production is not unexpected since T cell immune response 
requires MHC recognition (Clark, 1983). 
Genetic association of IL-2 production of the Sl line 
Analysis of variance of the partially inbred SI line indicate that 
the effects of the genes encoding Ea-8 type and immune response to GAT 
but not immune response to RSV-induced tumors significantly influence 
levels of IL-2 production (Table 12). It should be emphasized at this 
point that the genes coding for Ea-8 type, high or low immune response to 
GAT, and regression or progression of RSV-induced tumors have been shown 
to be associated or linked with the MHC (Schierman and Nordskog, 196I; 
Benedict et al., 1975; Schierman et al., 1977) It is therefore 
unexpected, based on a lack of association between MHC genes and IL-2 
levels seen in earlier studies of murine and avian IL-2 and on the 
results of the inbred lines study, to see a significant association of 
the MHC and levels of IL-2 production (Farrar et al., 1982; Schauenstein 
et al., 1985). In addition, since the effects of the genes controlling 
Ea-8 type and immune response to GAT are significant, the effect of the 
gene controlling the response to RSV-induced tumors would have also been 
expected to be significant because these genes have been shown to be 
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closely linked (Gebriel and Nordskog, 1983). 
A possible explanation for the contrasting results between the 
inbred lines study and Sl line study is that there may be more than one 
gene locus controlling levels of IL-2 production. It appears that at 
least one gene locus is located outside the MHC and one gene locus may be 
encoded within the MHC. The results of the inbred lines study provide 
preliminary evidence of this possibility. Within the inbred lines, both 
MHC and non-MHC influences are observed although the effects of the MHC 
only approached significance at the 5% probability level. The results of 
the Sl line study, however, clearly support the possibility of MHC 
influences on levels of IL-2 production. 
The heterogeneity of the Sl background genes may be one reason why 
non-MHC influences are not observed within the Sl line. As stated 
previously, it is probable that a non-MHC gene locus controlling a 
particular level of IL-2 production has not been fixed within the Sl line 
because the Sl line is not highly inbred. As a result of the variability 
of this gene locus in the non-MHC region, the effects of MHC influences 
on levels of IL-2 production are observable within the Sl line. 
As stated previously, the ability to respond to RSV-induced tumors 
has been shown to be linked with the immune response to GAT and Ea-8 type 
(Gebriel and Nordskog, 1983; Schierman et al., 1977). Therefore, an 
accordant effect on levels of IL-2 production would have been expected. 
This is not the case, however (Table 12). Unlike the association of Ea-8 
type and immune response to GAT on levels of IL-2 production, the effects 
of the ability to respond to RSV-induced tumors was not significantly 
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associated with IL-2 production. In addition, there was an inverse 
relationship between the effects of the ability to respond to RSV-induced 
tumors and the immune response to GAT and Ea-B type on levels of IL-2 
production (Table 13). 
The reason for the differences observed between the effects the 
ability to respond to RSV induced tumors and the effects of the gene loci 
controlling immune response to GAT and Ea-B type on levels of IL-2 
production may be explained by the fact that the Ea-B and GAT were held 
constant in sublines when selecting for regression or progression of RSV-
induced tumors. As a result, selection may have been primarily for non-
MHC loci controlling RSV tumor response. Collins et al. (1980) have 
shown that non-MHC loci also influence the ability to regress or progress 
RSV-induced tumors. Because the first and second order interactions 
between RSV and MHC (immune response to GAT and Ea-B type) are 
significant, this lends credence to the notion that more than one gene 
locus controls levels of IL-2 production, and at least one locus is 
within and one is outside the MHC. 
The possibility that at least two different loci may be controlling 
levels of IL-2 production, at least in this assay system, is supported by 
an earlier study by Morrow and Abplanalp (1981). They showed that 
proliferation in response to Con A is mediated by at least two different 
loci, one linked to the MHC (Con A2) and at least one located outside the 
MHC (Con Al). 
It is conceivable, therefore, that differing levels of IL-2 
production may be attributed to the same genetic control as that 
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influencing the immune response to Con A in IL-2 producing cells. Kromer 
et al. (1984) reported a high correlation between proliferation in 
response to Con A and levels of IL-2 production. Another report from 
their laboratory suggests that non-MHC control of the immune response to 
Con A accounts for differences in levels of IL-2 production (Schauenstein 
et al., 1985). Their results do not discount the possibility that levels 
of proliferation in response to Con A may be influenced by the ability to 
produce IL-2. The cells used in their studies contained a heterogeneous 
population of T lymphocyte subsets that included both cells that produce 
and cells that respond to IL-2. It is possible that levels of mitogen-
induced T cell proliferation may be a consequence of both Con A-
stimulation and response to the presence of IL-2. As a result, high 
levels of mitogen-induced T cell proliferation would be observed when 
high levels of IL-2 are measured. 
In order to determine whether levels of IL-2 production are 
genetically controlled or whether levels of IL-2 production are a 
consequence of the genetic control of the immune response to Con A, an 
assay system that greatly reduces or eliminates non-IL-2-induced 
proliferation should be used. This could be accomplished by comparing 
the levels of proliferation of a homogeneous population of Con A induced 
TH cells (i.e., IL-2 producing cells) with the levels of IL-2 produced by 
this population. The use of homogeneous populations of IL-2 producing 
cells would eliminate the effects of other cells and their soluble 
factors that also influence T cell proliferation. Because IL-2 producing 
cells will not respond to IL-2, their proliferation should be a result of 
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the activation by Con A. Moreover, to distinguish between IL-2 and other 
soluble factors that may also be present, antibody to avian IL-2 could be 
used to detect levels of IL-2 directly from the CM. Therefore, by 
comparing the levels of response due to Con A activation and levels of 
IL-2 measured directly from the CM, it may be possible to distinguish 
between the genetic control of response to Con A and levels of IL-2 
production. The absence of a correlation would indicate that levels of 
IL-2 production are genetically controlled independent of Con A response. 
This experiment cannot be performed at this time because avian 
immunologists have not developed the reagents to identify and separate T 
lymphocyte subsets. 
Associations of Levels of IL-2 Production and Disease 
The association between abnormal levels of IL-2 production and a 
variey of disease states and immune disorders is well-documented (for a 
review, see Kromer et al., 1986; Welte and Mertelsmann, 1985). In this 
study, the inherent ability of each genotype to produce IL-2 is compared 
with their known ability to respond to different antigenic challenges. 
It should be emphasized that the birds were not assayed for levels of IL-
2 production during antigenic challenge. The objective of this work is 
to examine the possibility of an association between differences of 
"normal" levels (unchallenged birds) of IL-2 production and immune 
response to different disease challenges. 
As described previously, there is a significant association between 
the immune response to GAT and levels of IL-2 production. As illustrated 
in Table 13, high responders to GAT produced significantly higher levels 
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of IL-2 than low responders to GAT. There is not, however, an 
association between the ability to progress or regress RSV-induced tumors 
and levels of IL-2 production. Therefore, it appears the the humeral 
immune response to GAT but not to RSV-induced tumors may be associated 
with a genotype's inherent ability to produce IL-2. 
Steadham et al. (I987) have demonstrated that BIBI birds were 
significantly more resistant to Marek's disease than BI9BI9 birds of the 
SI line. High responders to GAT, within each Ea-B type, were 
significantly more resistant to Marek's disease than low responders to 
GAT. In addition, they observed that there was not an association 
between resistance to Marek's disease and immune response to RSV-induced 
tumors, as demonstrated previously (Calnek et al., I975). The results of 
this study correlate with the results of Steadham and his associates. 
Similar trends of significance of levels of IL-2 production are observed 
with the relative ability to resist Marek's disease. Genotypes with 
higher levels of IL-2 production also are more resistant to Marek's 
disease. This may suggest that resistance to Marek's disease (a 
lymphoproliferative disease) may be associated with the ability to 
produce IL-2. 
Lamont et al. (I987) have demonstrated a highly significant 
association between resistance to £... multocida (etiological agent of fowl 
cholera) and Ea-B type of the SI line. The association between response 
to GAT and resistance to £... multocida was less significant, and the RSV 
tumor response was not significant. A similar relationship of 
significance of IL-2 levels is observed within the SI line. The 
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genotypes with higher IL-2 levels are more resistant to fowl cholera. It 
is possible that the inherent ability to produce IL-2 may influence the 
ability to resist£.... multocida. 
Comparisons of the trends of significant influences between immune 
response to an antigenic challenge and levels of IL-2 production are 
offered as possible avenues of further investigation. This study is 
designed to determine relative levels of IL-2 production in unchallenged 
birds. Additional studies that investigate the relationship between 
levels of IL-2 production and disease should be performed on challenged 
birds to confirm the role of IL-2 in avian disease resistance. 
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SUMMARY 
Interleukin-2 is a soluble immunoenhancing factor that plays a 
central role in the augmentation of cell-mediated immune responses and 
may also influence T-dependent B cell responses. Because of the 
importance of IL-2 in the immune system, a great deal of work has been 
done in ascertaining its mechanism of action. The study of avian IL-2, 
however, was not possible until an effective and efficient avian IL-2 
assay was recently developed. The avian IL-2 assay has been utilized in 
this study to examine relative levels of IL-2 production of the various 
genetic stock at the Iowa State Poultry Research Center. 
The results of this study indicated that there is genetic control of 
levels of IL-2 production in the chicken. Because two different genetic 
model systems were used in this study, MHC as well as non-MHC influences 
on levels of IL-2 production could be examined. The study of the inbred 
lines indicated that the genetic control of IL-2 production was a result 
of non-MHC genes. The study of the partially-inbred Sl line, on the 
other hand, indicated that genetic control of IL-2 production was due to 
MHC genes. Therefore, the combined results of both genetic model systems 
indicate there may be at least two gene loci, one encoded outside and one 
encoded inside the MHC, controlling levels of IL-2 production. 
This study does not discount the possibility that differing levels 
of IL-2 production may be a consequence of the genetic control of the 
immune response to Con A. Because Con A was used as the source of 
antigenic stimulation, it is possible that differences of levels of IL-2 
production measured are a result of the genetic control of the immune 
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response to Con A. The responding cells in this study, however, were 
washed thoroughly and cultured in the presence of a Con A inhibitor to 
insure that the effect of any residual Con A would not influence the 
levels of IL-2 measured. 
The possibility that the inherent ability to produce IL-2 affected 
disease resistance was also examined. Resistance to Marek's disease and 
fowl cholera but not to RSV-induced tumors was associated with the 
ability to produce IL-2. 
The study of the role of IL-2 in the avian immune system is in its 
infancy. There is a great deal of work yet to be done in the examination 
of the role of IL-2 in the avian immune system. Because of the 
phylogenic difference between mammals and aves, the study of the avian 
immune system and the factors that govern its activity should prove 
useful in understanding the evolution of the immune system. 
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